Source link : https://www.newshealth.biz/health-news/duchenne-drug-fails-confirmatory-trial-covid-brain-changes-first-seizure-clinics/
Preliminary data showed that viltolarsen (Viltepso), an exon-skipping drug that won accelerated approval to treat Duchenne muscular dystrophy in 2020, failed a 48-week phase III confirmatory trial, NS Pharma said. NG2 glia may protect against prion neurotoxicity by inhibiting prostaglandin E2 signaling from microglia to neurons, lab and animal studies suggested. (Nature Neuroscience) An artificial-intelligence […]
Author : News Health
Publish date : 2024-05-28 16:04:57
Copyright for syndicated content belongs to the linked Source.
Categories